Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liver Neoplasms × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3 Agnosia 2 Vesico-Ureteral Reflux 1 Ureteral Neoplasms 1 Pain 1 Nephrolithiasis 1 Multiple Myeloma 1 Lymphoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

Bevacizumab 9 pembrolizumab 5 lenvatinib 5 durvalumab 5 atezolizumab 5 fludarabine 4 Cyclophosphamide 4 tremelimumab 3 camrelizumab 3 apatinib 3 Ipilimumab 3 regorafenib 2 Riluzole 2 Radiotherapy 2 Nivolumab 2 Magnetic Resonance Imaging 2 Idarubicin 2 Blood Specimen Collection 2 Biopsy 2 yttrium chloride 1 trastuzumab deruxtecan 1 spartalizumab 1 sintilimab 1 pertuzumab 1 fludarabine phosphate 1 ferric carboxymaltose 1 epigallocatechin gallate 1 donafenib 1 cemiplimab 1 brodalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡